Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
Central South University · Hunan Cancer Hospital · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
13
total citations
- FWCI
- 156.54
- Percentile
- 100%
- References
- 39
Too recent for citation history.
Authors
28Topics & keywords
Topics
Keywords
- Hazard ratio
- Clinical endpoint
- Adverse effect
- Confidence interval
- Randomized controlled trial
- Lung cancer
- Phases of clinical research
- Retrospective cohort study
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.